LNK (SH2B3): Paradoxical effects in ovarian cancer

Oncogene

Volumn 34, Issue 11, 2015, Pages 1463-1474

  Ding, L W ^a   Sun, Q Y ^a   Lin, D C ^a,b   Chien, W ^a   Hattori, N ^a   Dong, X M ^c   Gery, S ^b   Garg, M ^a   Doan, N B ^d   Said, J W ^d   Xiao, J F ^a   Yang, H ^a   Liu, L Z ^a   Meng, X ^a   Huang, R Y J ^a   Tang, K ^c   Koeffler, H P ^a,b,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LNK PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN 14 3 3; PROTEIN BINDING; PROTEIN KINASE B; YWHAB PROTEIN, HUMAN;

ANIMAL; CANCER TRANSPLANTATION; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CELL SIZE; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

14-3-3 PROTEINS; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SIZE; FEMALE; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PROTEIN BINDING; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84897352171     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.34     Document Type: Article

References (47)

1. Devalliere J, Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol 2011; 82: 1391-1402.
2. Li Y, He X, Schembri-King J, Jakes S, Hayashi J. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 2000; 164: 5199-5206.
3. Rudd CE. Lnk adaptor: novel negative regulator of B cell lymphopoiesis. Sci STKE 2001; 2001: pe1.
4. Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnkdeficient mice. J Exp Med 2002; 195: 1599-1611.
5. Takaki S, Morita H, Tezuka Y, Takatsu K. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med 2002; 195: 151-160.
6. Tong W, Lodish HF. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 2004; 200: 569-580.
7. Buza-Vidas N, Antonchuk J, Qian H, Mansson R, Luc S, Zandi S et al. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev 2006; 20: 2018-2023.
8. Seita J, Ema H, Ooehara J, Yamazaki S, Tadokoro Y, Yamasaki A et al. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci USA 2007; 104: 2349-2354.
9. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 2005; 105: 4604-4612.
10. Baran-Marszak F, Magdoud H, Desterke C, Alvarado A, Roger C, Harel S et al. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms. Blood 2010; 116: 5961-5971.
11. Gery S, Cao Q, Gueller S, Xing H, Tefferi A, Koeffler HP. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leukoc Biol 2009; 85: 957-965.
12. Gery S, Gueller S, Chumakova K, Kawamata N, Liu L, Koeffler HP. Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders. Blood 2007; 110: 3360-3364.
13. Simon C, Dondi E, Chaix A, de Sepulveda P, Kubiseski TJ, Varin-Blank N et al. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Blood 2008; 112: 4039-4047.
14. Gueller S, Gery S, Nowak V, Liu L, Serve H, Koef fler HP. Adaptor protein Lnk associates with Tyr(568) in c-Kit. Biochem J 2008; 415: 241-245.
15. Gueller S, Goodridge HS, Niebuhr B, Xing H, Koren-Michowitz M, Serve H et al. Adaptor protein Lnk inhibits c-Fms-mediated macrophage function. J Leukoc Biol 2010; 88: 699-706.
16. Gueller S, Hehn S, Nowak V, Gery S, Serve H, Brandts CH et al. Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling. Exp Hematol 2011; 39: 591-600.
17. Lin DC, Yin T, Koren-Michowitz M, Ding LW, Gueller S, Gery S et al. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3. Blood 2012; 120: 3310-3317.
18. Hurtado C, Erquiaga I, Aranaz P, Migueliz I, Garcia-Delgado M, Novo FJ et al. LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation. Leuk Res 2011; 35: 1537-1539.
19. Ha JS, Jeon DS. Possible new LNK mutations in myeloproliferative neoplasms. Am J Hematol 2011; 86: 866-868.
20. Lasho TL, Pardanani A, Tefferi A. LNK mutations in JAK2 mutation-negative erythrocytosis. New Engl J Med 2010; 363: 1189-1190.
21. Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs KDJr. et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 2010; 116: 988-992.
22. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157-163.
23. Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 2012; 22: 153-166.
24. Perez-Garcia A, Ambesi-Impiombato A, Hadler M, Rigo I, Leduc CA, Kelly K et al. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood 2013; 122: 2425-2432.
25. Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet 2013; 45: 1293-1299.
26. Bersenev A, Wu C, Balcerek J, Jing J, Kundu M, Blobel GA et al. Lnk constrains myeloproliferative diseases in mice. J Clin Invest 2010; 120: 2058-2069.
27. Devalliere J, Chatelais M, Fitau J, Gerard N, Hulin P, Velazquez L et al. LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets alphaparvin to control cell adhesion and migration. FASEB J 2012; 26: 2592-2606.
28. Fitau J, Boulday G, Coulon F, Quillard T, Charreau B. The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 2006; 281: 20148-20159.
29. Chatelais M, Devalliere J, Galli C, Charreau B. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection. Xenotransplantation 2011; 18: 108-120.
30. Gery S, Gueller S, Nowak V, Sohn J, Hofmann WK, Koeffler HP. Expression of the adaptor protein Lnk in leukemia cells. Exp Hematol 2009; 37: 585-592 e582.
31. Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med 2013; 5: 983-998.
32. Jiang J, Balcerek J, Rozenova K, Cheng Y, Bersenev A, Wu C et al. 14-3-3 regulates the LNK/JAK2 pathway in mouse hematopoietic stem and progenitor cells. J Clin Invest 2012; 122: 2079-2091.
33. Maures TJ, Chen L, Carter-Su C. Nucleocytoplasmic shuttling of the adapter protein SH2B1β (SH2-B β) is required for nerve growth factor (NGF)-dependent neurite outgrowth and enhancement of expression of a subset of ngfresponsive genes. Mol Endocrinol 2009; 23: 1077-1091.
34. Gery S, Koeffler HP. Role of the adaptor protein LNK in normal and malignant hematopoiesis. Oncogene 2012; 32: 3111-3118.
35. Oh ST. When the brakes are lost: LNK dysfunction in mice, men, and myeloproliferative neoplasms. Ther Adv Hematol 2011; 2: 11-19.
36. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752.
37. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124: 471-484.
38. Ahmed Z, Pillay TS. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinasedependent signalling. Biochem J 2003; 371: 405-412.
39. Nishi M, Werner ED, Oh BC, Frantz JD, Dhe-Paganon S, Hansen L et al. Kinase activation through dimerization by human SH2-B. Mol Cell Biol 2005; 25: 2607-2621.
40. Qian X, Ginty DD. SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol 2001; 21: 1613-1620.
41. The-Cancer-Genome-Altas-Research-Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615.
42. Werz C, Kohler K, Hafen E, Stocker H. The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway. PLoS Genet 2009; 5: e1000596.
43. Almudi I, Poernbacher I, Hafen E, Stocker H. The Lnk/SH2B adaptor provides a failsafe mechanism to establish the Insulin receptor-Chico interaction. Cell Commun Signal 2013; 11: 26.
44. Lanning NJ, Su HW, Argetsinger LS, Carter-Su C. Identification of SH2B1beta as a focal adhesion protein that regulates focal adhesion size and number. J Cell Sci 2011; 124: 3095-3105.
45. Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H et al. Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev Cell 2008; 15: 371-385.
46. Lee JI, Dominy JEJr., Sikalidis AK, Hirschberger LL, Wang W, Stipanuk MH. HepG2/ C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway. Physiol Genomics 2008; 33: 218-229.
47. Dawson MA, Bannister AJ, Gottgens B, Foster SD, Bartke T, Green AR et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009; 461: 819-822.